Pediatric Immunization Clinical Trial | DTaP-IPV Utah Study – Infants

***JBR Clinical Research is not accepting new applicants for this study at this time. If you would like to be considered for other studies, please submit a form on our Healthy Volunteers Study page or call us at 801-261-2000. Thank you!***

JBR Clinical Research is conducting a clinical research study for an investigational immunization vaccine for infants 46-89 days old.

Participants that are selected for the study will receive a no cost vaccination, health care related to the study, and compensation up to $325 for time and travel.

Basic qualifications are:

  • 46-89 days old
  • Healthy Male or Female
  • Subject must not have received the DTaP or DTwP vaccination prior to study entrance.
  • Must have had only one dose of a hepatitis B vaccine

If you qualify you may receive:

  • Study related exam
  • No cost investigational vaccination
  • Compensation up to $325 for time and travel related to the study

For more information about Pediatric Vaccinations, read the following information from the American Medical Association’s website.

About Pediatric Vaccinations

One of the greatest public health success stories is the remarkable decrease in infectious diseases due to the use of vaccines. Unfortunately, the immense success of vaccination in America has lulled many parents into complacency with regard to vaccine preventable diseases like measles, meningitis, polio and diphtheria. In order for previous successes to be maintained, the public and their appointed legislators must realize these diseases still exist and can still debilitate and kill.

Vaccines are available for 20 different infectious diseases, and vaccines against 10 deadly diseases are recommended for use in all U.S. children. Vaccines not only protect the child that receives them, but just as important, they protect the health of the community in which the child lives.

A scientific study in theJournal of the American Medical Association indicated that those who did not receive measles vaccine due to philosophical or religious reasons were 35 times more likely to contract measles, and could potentially increase the incidence of measles in their community by as much as 30 percent.

When vaccination levels are high, children who cannot be protected directly by the vaccines are protected because they are not exposed to the disease. This includes children too young to receive vaccinations and those with medical contraindications such as a child with leukemia who cannot receive the measles vaccine.

Without vaccines, epidemics of vaccine-preventable diseases could return, resulting in increased illness, disability, and death. With the eradication of some diseases, such as polio, so close at hand, any reduction in vaccination coverage for these diseases could erase many years of hard work and have an enormous negative impact on the public health of the United States.